Skip to main content
. 2020 Aug 13;12(8):2262. doi: 10.3390/cancers12082262

Table 3.

Correlation between eIF4G Expression and Clinicopathological Characteristics in HCC Patients.

Characteristic Group eIF4G High Expression eIF4G Low Expression p Value
Gender Male 13 3 0.6300
Female 6 3
Age (years) <50 1 2 0.1326
≥50 18 4
AFP (ng/mL) <400 11 6 0.1292
≥400 8 0
Etiology Hepatitis B 1 1 0.0812
Hepatitis C 7 0
Alcohol 6 0
NASH 1 1
Autoimmune 0 1
Vinyl chloride 1 0
Colorectal metastasis 0 1
Unknown 3 2
Liver cirrhosis Present 10 2 0.6447
Absent 9 4
Tumor size (cm) <5 13 4 >0.9999
≥5 6 2
Tumor number Single 13 6 0.2778
Multiple 6 0
Edmondson-Steiner grade G1 0 1 0.0694
G2 10 4
G3 9 1
ECGO PS 0 18 5 0.4300
1 1 1
Child-Pugh class A 19 5 0.2400
B 0 1
BCLC stage 0 + A 15 5 >0.9999
B 4 1
TNM stage I + II 11 5 0.3644
III 8 1
Recurrence Positive 10 2 0.6447
Negative 9 4
Recurrence Pattern Intrahepatic only 9 0 0.0271 *
n = 12 Extrahepatic only 0 1
Both 1 1
Ki-67 expression High 9 2 0.6609
Low 10 4
Midkine expression High 12 3 0.6532
Low 7 3
Patient survival (%) 1-year OS 75.89 100 >0.9999
1-year PFS 41.32 80 0.0953
3-year OS 38.55 100 0.1861
3-year PFS 27.55 80 0.2774
5-year OS 0 100 0.1753
5-year PFS 0 80 0.2335

Abbreviations: *, p < 0.05.